Introduction
============

Gastrointestinal pathogens invade or disrupt the intestinal barrier by the action of secreted toxins. They can alter cell physiology by multiple mechanisms, being directly responsible for the pathology of the disease or favoring other processes such as manipulation of the host immune response, escape from the intracellular environment and penetration of host barriers, among others ([@B90]). The *Vibrionaceae* family includes several species of major importance in the clinical field that are able to cause gastroenteritis. Among these, *Vibrio cholerae* is the classical pathogen carrying an arsenal of diverse toxins that produce illness. This bacterium is the agent responsible for cholera, an infection of the small intestine whose classical symptoms are a watery diarrhea, vomiting and dehydration; it is associated with million cases and several deaths around the world each year. ([@B94]; [@B69]). Serotypes O1 and O139, mainly responsible for acute diarrheal disease, possess two main virulence genes, the cholera toxin (CT) and the toxin-coregulated pilus (TCP). However, other strains (non-O1/non-O139) that cause sporadic cases of diarrhea have toxigenic potential attributed to secretion systems (T3SS and T6SS) and other accessory toxins like zonula occludens toxin (Zot) ([@B17]). Additionally, they have other genes, coding to hemolysins and repeats in toxin (MARTX) which have role helping to the colonization of the intestine ([@B48]). Additionally, accessory cholera enterotoxin (Ace) causes fluid secretion in ligated rabbit ileal loops ([@B88]) while cholix toxin (ChxA) is an exotoxin which has been characterized as a member of the eukaryotic elongation factor 2-specific ADP-ribosyltransferase toxins ([@B48]). *V. cholerae* is not the only *Vibrio* producing toxins; other members of the *Vibrionaceae* family also produce toxins that generate illness. Although it is not its primary pathology, *V vulnificus* is capable of producing gastroenteritis among its clinical manifestations. This pathogen secretes a number of exotoxins and enzymes ([@B57]), among which the cytolysin VvhA ([@B47]) and metalloprotease Vvp ([@B52]; [@B20]) are the most important join to RTX. This last toxin has been strongly associated with the virulence of this organism ([@B53], [@B52]). It is suggested that this toxin might protect the bacterium from phagocytosis, promoting their survival. Surprisingly, sequencing of *V. vulnificus* MO6-24/O strain isolated from a septicemic patient showed that this strain possessed a phage-related gene cluster containing *ace* and *zot* genes ([@B67]). Similarly, a recent study showed that some strains of *Vibrio parahaemolyticus* lacking the classical toxins TDH and TRH possess genomic islands and prophage elements containing RTX, Zot and Ace toxins. Zot has also been found in prophage f237 of the pandemic strain and in prophage-like elements in *V. coralliilyticus* and *V. anguillarum*, suggesting that the horizontal gene transfer (HGT) associated to phages coding *zot* occurs frequently among *Vibrio* species ([@B14]). If pathogenicity genes are combined by HGT at high frequency the probability of generate new virulent species increases ([@B62]), which is favored in estuaries and marine environments which represent a extensive pool of virulence genes associated to species of the genus *Vibrio* ([@B15]; [@B45]).

Martine Urtaza and their collaborators recently shown that the risk of infections associated to *Vibrio* species is rising in many parts of the world ([@B60]), and as a consequence of global warming, it is expected that cases would be increasing in frequency and intensity. The broad spectrum of toxins found in the genomes of *Vibrios* draws attention to which toxins are essential in the development of gastroenteritis and which others are responsible for extra-intestinal infections. An unequivocal knowledge of the mechanisms responsible of the development of infection is crucial to establish new precautionary measures and treatments. The goal of this study is to gain understanding about the distribution of accessory toxins in human pathogenic *Vibrios* and to review the advancement in the study of the role of these toxins in the intestinal epithelium during infection by different *Vibrio* pathogens.

The Intestinal Barrier: The Role of Tight Junctions (TJs) Proteins
==================================================================

The intestines are organs in the digestive system tract involved in the uptake of nutrients and water ([@B27]). They also represent a barrier against pathogens of the outside environment. Due to the protection function, intestinal permeability is a highly regulated dynamic process. The intestinal barrier is mainly composed of three layers: mucus, epithelia, and the lamina propria ([@B48]). The epithelial layer is a single layer of cells, which selectively regulate the absorption of nutrients and prevent or modulate the access of microorganisms, toxins and other macromolecules from the intestinal lumen ([@B76]). The epithelial cells that make up the barrier are maintained together by specialized intercellular junctions: desmosomes, adherens junctions (AJs) and tight junctions (TJs) ([@B21]; [@B90]). All of them, in addition to the intestinal microbiota and immunogenic mechanisms, possess a joint crucial role to maintain the appropriate function of the intestinal barrier. Consequently, the well-functioning of this barrier strongly depends on the normal function of the paracellular pathway ([@B27]). Tight junctions, also called *zonulae occludentes*, are the intercellular junctions most apically located (**Figure [1](#F1){ref-type="fig"}**; [@B39]) and interruption of these junctions contributes to the inflammatory response because of increased antigenic penetration ([@B3]). These junctions also regulate the selective paracellular permeability to solutes, ions, water and various macromolecule ([@B93]) and the entry of microorganisms inhabiting in the intestinal mucosa ([@B90]). This barrier function is conferred by a large and diverse group of transmembrane proteins mainly composed of proteins claudins, occludins, and the zonula occludens-associated (ZO) proteins 1, 2, and 3 ([@B51]) among others. The cytosolic scaffold protein ZO-1 directly and indirectly couples occludin and claudins to the other cytoplasmic TJ proteins ([@B89]) and the actin cytoskeleton (**Figure [1](#F1){ref-type="fig"}**).

![Intercellular junctions. Schematic draw of the intercellular junctions showing **(A)** tight junction, **(B)** adherens junction, **(C)** desmosome, and **(D)** gap junction. *In detail to the right of the figure*: Tight junctions are multiprotein complexes containing members of the claudins (in blue), occludin (in red), and junctional adhesion molecules (JAMs, in green color) families.](fmicb-09-02248-g001){#F1}

TJ assembly and disassembly is a dynamic process that involves endocytosis, migration and recycling in all epithelia. The regulation of TJs occurs by PKC activation affecting stability in the dynamic TJ complex. This is coincident with increases in paracellular permeability mediated by TJ ([@B89]). Several pro-inflammatory cytokines can also modulate TJ dynamics causing disruption of the intestinal TJ barrier and resulting in an increase of intestinal TJ permeability ([@B2], [@B3], [@B4]) while anti-inflammatory cytokines were shown to promote intestinal TJ barrier function ([@B4]). Other factors that impact TJ dynamics and assembly includes intracellular cAMP and calcium imbalance among others, which act through their varied effects on cellular kinases ([@B48]). Another structure indispensable for the integrity of paracellular pathway is the cytoskeleton. The cytoskeleton is the structure that maintains the shape and internal organization of the cells, besides giving mechanical support to carry on cellular movement and division. The interaction of TJ proteins with the actin maintain the structure of cytoskeletal, which is essential for the proper regulation of barrier functioning ([@B38]).

The Interaction Between the Intestinal Barrier and Pathogenic Microorganisms
============================================================================

The epithelia comprise structures adapted to protect the tissues from pathogenic microorganisms, antigens and/or proinflammatory factors ([@B27]; [@B87]). Conversely, pathogens have generated diverse strategies that disrupt the components that maintain the structure of epithelia and spread to various tissues ([@B87]; [@B26]). Pathogens can secrete enzymes that affect the extracellular part of junction components or toxins acting within the cell, disrupting intercellular junctions. Other can inject effector proteins into the host cell cytoplasm, altering cell functions by acting on cell signaling pathways ([@B90]). Invasive pathogens can destabilize the junctions by inducing a signaling cascade that lead to proinflammatory response or directly targeting the intercellular junction. The cytoskeleton is also a target for toxins by direct and indirect modifications through covalent or non-covalent mechanisms, respectively ([@B8]). The mechanism of action is different among toxins, some of them shift the equilibrium between F- (polymerized) and G-actin (monomeric) ([@B49]), while other can affect directly actin.

The interactions between the enteric pathogenic microorganisms and their hosts is of great interest to try to understand several mechanisms of infectious diseases. The relationship between the toxic products of bacteria and diarrheal diseases has been studied extensively ([@B40]). Although one of the function of the epithelial barriers is to block the access of many organisms, certain pathogens have evolved to alter this barrier. In this context, most of gastrointestinal pathogens lead to intestinal secretion by elaboration of toxins or invasion ([@B28]). They can use tight junction proteins as receptors for their internalization or destroy the junctions to enter to the underlying tissue. As a result, the altering of tight junctions elicit inflammatory cascades causing diarrhea as the ultimate goal ([@B26]).

The *V. cholerae* Pathogenesis: The Cholera Toxin
=================================================

Since cholera is a global disease responsible for several cases of diarrhea and deaths around the world, the mechanisms of pathogenicity of this pathogen have been deeply studied (WHO (2015) *Cholera: Fact Sheet No. 107).* The cholera disease is an acute infectious diarrhea whose transmission occurs mainly through contaminated water or foods. Once this pathogen interacts with the epithelial cells of the human small intestine a massive watery efflux occurs characteristic of cholera diarrhea, which functions to disperse *V. cholerae* back into the environment. Therefore, the diarrhea causes severe dehydration and in many cases the death of infected people ([@B22]).

The pathogenesis of cholera is a multifactorial process involving several genes that encode virulence factors that help the bacteria in colonization and the expression of the cholera toxin (CT). Each CT molecule is composed of one A subunit plus five B subunits. The B subunits bind to the ganglioside GM1 receptors in the epithelial cells of the intestinal mucosa. After binding, subunits A1 and A2 are separated, which facilitates the entry of component A1 into the cell. Component A1 of the CT stimulates the production of the enzyme adenyl cyclase, involved in the production of cyclic adenosine monophosphate (cAMP) ([@B11]). The high intracellular concentrations of cAMP alter the transport of electrolytes through the cell membrane, activating the cystic fibrosis transmembrane conductance regulator (CFTR) and resulting in secretion of chloride ions into the lumen. The receptor for the CT is composed of flexible homopolymers of the monomeric form of the toxin-coregulated pili (TCP) pilin subunit TcpA that self-associates, holding cells together in microcolonies. All the *ctxAB* operon is part of the genome of the filamentous bacteriophage CTXf, lysogenized in the bacterium ([@B29]; [@B96]; [@B66]). Besides CT, it also carries the genes involved in the morphogenesis of the bacteriophage (*psh, cep, orfU*, and *ace*) and a gene that encodes a protein necessary for the assembly of the virion (*zot*). Both gene products, Zot and Ace, are also able to contribute to *V. cholerae* pathogenesis by inducing changes in the intestinal barrier ([@B29]; [@B9]; [@B28]; [@B19])

The Zot Toxin
-------------

Zonula occludens toxin (Zot) was discovered in *V. cholerae* when live oral vaccines, constructed by deletion of *V. cholerae* sequences encoding the A subunit of the CT, were applied to volunteers. These strains still provoked diarrhea (mild to moderate) in some volunteers due to the presence of another toxin that interacts with tight junctions affecting the paracellular pathway ([@B29]). Zot is also encoded in the bacteriophage CTXf; its N-terminal side is involved in phage morphogenesis. In fact, a *zot* mutation impairs the release of phage particles into the culture supernatant ([@B91]). The C-terminal is secreted into the intestinal lumen after clivage ([@B29]; [@B80]). Studies have shown that a smaller fragment of 12 kD is the fragment of Zot with biological activity ([@B23]). The enterotoxic and permeabilizing effect of Zot on rabbit small intestine was first shown by Fasano and collaborators. They described that Zot has a regional effect which varies in the different segments of rabbit intestine ([@B30]). Later, Uzzau and coworkers demonstrated that Zot induces a transitory reduction in transepithelial electrical resistance and an increase in transepithelial flux, increasing the permeability of TJs ([@B92]). They also identified the Zot region required for receptor binding. The Zot receptor is a protein that is located on the cell surface and acts by modulating the cytoskeleton and the tight junction complex inside of the cell ([@B92]). Currently it is known that Zot is positioned in the cell envelope of bacteria ([@B23]; [@B75]) and that its action is mediated by intracellular signaling that leads to a reduces the actin filaments (changing the F- and G-actin pools, **Figure [2](#F2){ref-type="fig"}**). The change of actin microfilaments increases intestinal epithelial permeability by affecting the TJs ([@B51]; [@B37]). It has been demonstrated that Zot increases the transport of diverse macromolecules such as insulin, sucrose and acyclovir across several surfaces, including blood-brain barrier and mucosal ([@B39]).

![*V. cholerae* infection. Mechanism of action of *V. cholerae* toxins. The Cholera Toxin (CT) binds to the receptor (Ganglioside GM1) and enhances adenylate cyclase (Ac) activity, increasing cAMP. Elevated intracellular concentrations of cAMP activate the cystic fibrosis transmembrane conductance regulator (CFTR), resulting in secretion of chloride ions into the lumen. Zonula occludens toxin (Zot) affects the structure of the TJs increasing the permeability. Accesory cholera enterotoxin (ACE) stimulates Ca^2+^-dependent Cl^-^/HCO3^-^ secretion in intestinal cells. Heat stable enterotoxin (Sta) leads to the increase of cGMP inhibiting the regulatory mechanism of Na^+^/Cl^-^. The Repeats in toxin (RTX) leads to the depolymerization of stress fibers. Cholix Toxin (ChT) inhibits protein synthesis. Finally, although Hemagglutinin (HA)/protease (HA/P) is not a toxin, it produces the cleavage of occludin into two distinct fragments, affecting the paracellular pathway of intestinal epithelial cells in culture. The accessory toxins Zot, Ace and RTX are also found in the genome of other *Vibrio* species.](fmicb-09-02248-g002){#F2}

The ACE Toxin
-------------

The "virulence cassette" of *V. cholera*e includes genes encoding CT and Zot but also a third toxin called Ace ([@B88]; [@B6]). This last is an integral membrane protein consisting of 96 amino acids which alters ion transport, causes accumulation in ligated rabbit ileal loops and is responsible for mild diarrhea ([@B18]). Not much is known about this toxin because of the low amount produced by *V. cholerae*. Ace stimulates Ca^2+^ -dependent Cl^-^ /HCO^3-^ symporters in a colonic carcinoma T84 monolayer cell model, creating a potential difference across the membrane ([@B18], [@B19]).

Heat Stable Enterotoxin
-----------------------

Heat stable enterotoxin (ST) is a peptide composed of 17 aminoacids that induces Ca^2+^ release from the cell in response to IP3, leading to the activation of guanylyl cyclase and the production of cGMP ([@B5]). The increase in intracellular cGMP inhibit the regulatory mechanism of Na ^+^/Cl^-^ eliciting secretory diarrhea ([@B1]).

Repeats in Toxin
----------------

The repeats-in-toxin (RTX) proteins of Gram-negative bacteria have in common the mode of export via the Type I-Secretion System and classical C-terminal GD-rich repeats ([@B56]). The RTX family generally consists of hemolysins and cytolysins with molecular masses ranging between 40 and more than 600 kDa, that display a variety of activities ([@B56]; [@B25]) and are activated by acylation post-translationally ([@B32]). RTX pore-forming toxins involved in bacterial pathogenesis, characterized by repeats of a glycine and aspartate-rich, calcium-binding sequence motif are the members of RTX family most studied and known ([@B68]; [@B77]). The RTX toxins are four genes of two operons: *rtxA* encoding the toxin; *rtxB/rtxE*, an ATP-binding cassette transporter of RtxA; *rtxC*, an acylase of RtxA; and *rtxD*, with no clear function yet ([@B56]). They can act in a synergistic way, causing damage and triggering the liberation of inflammatory molecules ([@B12]). *In vitro*, these toxins show hemolytic and cytotoxic activity which induce damage to the membrane, osmotic changes and finally, cell death by lysis ([@B97]). However, in host cells the cytotoxicity of RTX toxins produces also apoptosis, although the mechanisms is not understood ([@B97]). The best characterized are the multifunctional-autoprocessing RTX (MARTX) toxins, a subgroup of very large RTX proteins (range from 3,500 to 5,300 aminoacid residues) with multiple activities and which constitute a combination of secreted toxins and multi-effector delivery systems ([@B98]). These proteins are encoded by *V. cholerae* (VcRtxA), *V. vulnificus* and other pathogens ([@B52]). In *V. cholerae* the MARTX~V\ c~ (MARTX of *V. cholerae)* is found in practically all strains (including environmental and clinical isolates and pandemic strains) ([@B61]; [@B16]). This toxin acts by avoiding the elimination of *V. cholerae* from the intestine at the beginning of infection ([@B78]). In this way, *V. cholerae* MARTX~V\ c~, contributes to the pathogenesis of cholera in model systems ([@B49]) although not possess the cytolytic (or hemolytic) activities displayed by other RTX toxins. MARTX~V\ c~, like CT and pore-forming toxin hemolysin, is associated with the ability to establish a persistent intestinal infection by bacteria ([@B70]; [@B65]). It has been shown that MARTX~V\ c~ directly catalyzes a covalent cross-linking of G-actin (monomer) into oligomeric chains, causing cell rounding by disassembly of the actine stress fibers in culture ([@B81]; [@B22]). Two distinct virulence activity domains in MARTX~V\ c~ are responsible for the toxin effect. Actin cross-linking domain causes irreversible disassembly of the cytoskeleton by directly catalyzing the covalent cross-linking of monomeric G-actin. The Rho GTPase inactivation domain causes inactivation of small GTP-bound Rho, Rac, and Cdc42, resulting in depolymerization of actin ([@B81]; [@B49]; [@B70]). In 2017, Chen and coworkers showed that MARTXs contain repeated motifs. In the C-terminus there are GD-rich repeats whereas the repeats at the N-terminus are required for toxin secretion and effector translocation ([@B20]).

Cholix
------

Cholix toxin (Cholix, ChxA) is a newly identified virulence factor reported in non-pandemic strains (non O1/non O139 *V. cholerae* strains; [@B71]). Cholix is a 70 kDa ADP-ribosyltransferase toxin that translocates into cells by receptor-mediated endocytosis ([@B64]; [@B63]) and utilizes eukaryotic elongation factor 2 (eEF2) as a substrate ([@B63]). The transference of an ADP-ribose group from NAD ^+^ to a diphthamide in eEF2 mediated by cholix inhibit the synthesis of protein producing finally cell death ([@B44]). Because of the similarity with exotoxin A, it is suggested that cholix toxin enters eukaryotic cells by endocytosis where it is cleaved and the catalytic domain is released to the cytosol where it exerts its effect. This toxin is active against mammal and crustacean cells ([@B31]), suggesting that it plays a role in the survival in their natural environment. Interestingly, the study of [@B7] showed that there are three types of cholix and none of them caused enterotoxicity in rabbits, however, two of them caused extensive damage in internal organs in mice, suggesting that cholix is associated with extraintestinal infections at least in one animal model ([@B7])

Hemagglutinin/Protease (HA/P)
-----------------------------

Although HA/P, the *V. cholerae* hemagglutinin/protease, is not a toxin, it has been described that can play a role during colonization of the intestine ([@B58]; [@B84]). HA/P is Zn-dependent metalloprotease with mucinase activity, encoded by *hapA* ([@B86]; [@B58]). It exhibit several activities including modification of toxins, degradation of the mucus barrier and acting on TJ-associated proteins, Cleavage of occludin by HA/P resulted in rearrangement of ZO-1, the F-actin cytoskeleton and disruption of paracellular barrier function ([@B86]; [@B10]). HA/protease also shows homology to *V. vulnificus* elastase (VvpE) at aminoacidic level, which is important due to VvpE contributes to local tissue damage during infections produced by this *Vibrio* ([@B54]).

Variation of RTX and CT and Their Impact in the *V. cholerae* Pathogenicity
===========================================================================

The first global spread of cholera disease, occurred from the early 1960s through the middle 1990s, was mainly associated to the El Tor strains of *V. cholerae*. However, since the late 1990s, a lineage known as the altered El Tor (AET) *V. cholerae* has come to predominate as the major cause of human cholera disease ([@B79]) and it has been associated to severe cases of diarrhea. Interestingly, although *V. cholerae* possess diverse variants of MARTX toxin associated to environmental strains able to produce disease, the AET *V. cholerae* strains have an inactivated MARTX toxin gene. This inactivation is explained because the *rtxA* toxin gene possesses one SNP that introduces a stop codon, resulting in a truncated protein ([@B24]). Despite the absence of RTX, these strains are more virulent ([@B79]), questioning if RTX is necessary for the pathogenicity of Vibrio. Some authors have proposed that this very large toxin is eliminated once it is not necessary, because it may be detrimental to growth due to energy costs ([@B24]). Besides, RTX is fully redundant in function with a pore-forming hemolysin ([@B65]).

Interestingly, the null mutant of *rtxA* was the genetic background for following emergence of the *ctxB7* allele, a point mutation in *ctxB* that created a CtxB with Asparagine at aminoacid 20 (H20 to N20 change) ([@B24]). The functional consequence of this change is unknown, but it is suggested that it may affect the maturation of the toxin ([@B79]). This is significant considering that the severity of cholera is associated with the production of CT, as El Tor strains carrying ctxB-1 were associated with more severe symptoms ([@B85]). Additional changes in the CTX gene resulted later in substitution of *ctxB*1 with *ctxB*7 ([@B74]).

Strains carrying *ctxB* allela were first detected in Odisha, India, in 2007 ([@B50]) and have been transmitted globally, reaching Cameroon (Africa) in 2009, Nepal in 2010 and Haiti in 2010 ([@B72]; [@B41]) where they produced a devastating outbreak.

Distribution of Toxins in Other Non-Cholerae *Vibrio*
=====================================================

Diarrhea associated with seafood consumption are mainly associated to pathogenic *V. parahaemolyticus* strains ([@B34]; [@B55]). Several characteristic virulence associated factors of this pathogen such as hemolysins TDH (thermostable direct hemolysin), TRH (TDH-related hemolysin) and the secretion systems ([@B13]; [@B15]; [@B73]) have been deeply studied. Nonetheless, the pathogenesis of *V. parahaemolyticus* is still not fully understood. Some studies have reported that environmental isolates of *V. parahaemolyticus* lacking most characteristic virulence factors (*tdh*, *trh*, and T3SS-2) are able to produce cellular damage ([@B59]; [@B14]; [@B95]) while others have reported clinical strains with absence of all principal virulence factors isolated with patients with gastroenteritis ([@B33]). These results indicate that classic virulence factors are not sufficient to explain the cytotoxicity and enterotoxicity of pathogenic *V. parahaemolyticus* strains and suggest that a novel virulence factor (or more than one) could be responsible for pathogenicity. A comparative genomic analysis of environmental and clinical strains of *V. parahaemolyticus* revealed the absence of most of the classical toxins and virulence factors described for *V. parahaemolyticus* in cytotoxic strains, but instead they had novel and uncharacterized toxins in the accessory genome, mainly associated with prophages and pathogenicity islands. Bioinformatics analysis revealed the presence of prophage-like elements which encoded a putative Zot-like enterotoxin ([@B14]). Interestingly, three phages contained three different *zot* sequences, suggesting high diversity within the same species. However, although *V. parahaemolyticus* and *V. cholerae* Zot shared only 24% amino acid identity, they share some conserved regions ([@B14]), suggesting that the structure acquired by Zot is more important than the sequence. Additionally, other *V. parahaemolyticus* strain, PMA 1.15, contained a prophage carrying a putative RTX toxin in addition a novel genomic island containing DNase and RTX toxin genes (see Figure 4 in [@B14]). However, until this manuscript appeared, no studies about the function of Zot or RTX in *V. parahaemolyticus* were published.

*V. vulnificus*, another important human pathogen, is distributed worldwide in estuaries and marine environments, where is associated to food-borne and wound infections exhibiting high mortality ([@B99]; [@B47]), which exceeds 50%, and can increases to more than 90% in patients in serious condition (shock) ([@B42]; [@B20]). This bacterium produces several virulence factors that cause disease, including cytolysin VvhA, metalloprotease Vvp, flagella and RtxA toxin among others ([@B52]; [@B20]). RtxA1 toxin is the most potent cytotoxic virulence factor ([@B53]) of *V. vulnificus* ([@B35]). It has been shown that it exerts dramatic effects on cytoskeletal rearrangement, contact cytotoxicity, hemolysis (inducing the apoptotic death of human epithelial cells ([@B47])), invasion and lethality to mice, showing that it is a multifunctional virulence factor of *V. vulnificus* ([@B53]). Like that of *V. cholerae*, the RTX of *V. vulnificus* has multiple domains and it is autoprocessed ([@B43]; [@B36]; [@B20]; [@B47]). Mutants on this toxin are significantly attenuated for virulence ([@B57]; [@B47]). A *V. vulnificus* null mutant in the *rtxA* gene constructed by [@B53] exhibited decreased cytotoxic activity, using NT-407 intestinal epithelial cells as model. MARTX~V\ v~ (multifunctional-autoprocessing repeats-in-toxins toxin of *V. vulnificus)* and the cytolysin VvhA play a role in growth of bacteria *in vivo*, therefore the presence of both factors is directly correlated with mouse mortality ([@B43]). The importance of N-termini and C-termini of MARTX~V\ v~ has been shown by [@B46]. A deletion in the C-terminal region blocked toxin secretion from the bacterium and consequently a reduction in the cytotoxicity of bacteria. In contrast, a deletion in the N-terminal domain completely abolished necrosis ([@B46]).

Interestingly, the complete genome sequence of *V. vulnificus* MO6-24/O isolated from a septicemic patient showed that this particular strain contains 272 specific genes, including phage-related genes. The gene cluster of the bacteriophage contains *ace* and *zot*, revealing genetic diversity resulting from extensive gene transfer ([@B67]).

Finally, although it is not considered as an important human pathogen until today, recent observations have indicated that *V. mimicus* may cause epidemic diarrhea. Some of these strains contains the "cholera virulence cassette" containing genes encoding Zot, Ace and a core encoded pilus as well as CT ([@B83], [@B82]).

Conclusion
==========

Risk of gastrointestinal infections associated with *Vibrio* species has been rising worldwide as a consequence of global warming. However, to date the mechanisms involved in the production of diarrhea by some *Vibrio* species is not completely understood. *V. cholerae* has an arsenal of toxins, the most important being the classical CT, but also Zot, RTX and Ace contribute to the enterotoxicity of this pathogen, while cholix produces extraintestinal effects (**Table [1](#T1){ref-type="table"}**). In *Vibrio* the HGT plays a significant role in the transmission of genes. In fact, bacteriophages and other mobile elements containing Zot, Ace and also RTX have been reported in the genomes of clinical and environmental strains of *V. parahaemolyticus* that exhibited high cytotoxicity. Also, a bacteriophage containing *zot* and *ace* genes was reported in a strain of *V. vulnificus* isolated from a patient with septicemia. Similarly, some strains of *V. mimicus* possess the virulence cassette of *V. cholerae.* Regrettably no studies of the characterization and function of these toxins were found until this manuscript was finished, and we do not know if they contribute to the pathogenicity of *V. parahaemolyticus* and *V. vulnificus*, and if they do, in what way. In the light of the facts, it seems urgent to know the molecular mechanisms behind the mode of action of these novel enterotoxins in *Vibrios* other than *V. cholerae*.

###### 

Classical and accessory toxins of *Vibrio cholerae* and reported in other *Vibrio* strains.

  Toxin                                   Microorganism           Main pathological effects   Main cellular effects                                                                            Reference
  --------------------------------------- ----------------------- --------------------------- ------------------------------------------------------------------------------------------------ ----------------
  Cholera toxin                           *V. cholerae*           Diarrhea                    Activation of adenylate cyclase, increase in cAMP, active secretion of electrolytes, and water   [@B96]
                                          *V. mimucus*            Diarrhea?                   Unkown                                                                                           [@B83]
  *Zot*                                   *V. cholerae*           *Diarrhea*                  *Increase permeability of epithelial barrier by opening of tight junctions*                      [@B29]
                                          *V. parahaemolyticus*   Diarrhea?                   Unkown                                                                                           [@B14]
                                          *V. vulnificus*         Diarrhea?                   Unkown                                                                                           [@B67]
                                          *V. mimucus*            Diarrhea?                   Unkown                                                                                           [@B83]
  Ace                                     *V. cholerae*           Diarrhea                    Alters ion transport increasing electrolyte and water secretion                                  [@B88]
                                          *V. parahaemolyticus*   Diarrhea?                   Unkown                                                                                           [@B14]
                                          *V. vulnificus*         Diarrhea?                   Unkown                                                                                           [@B67]
                                          *V. mimucus*            Diarrhea?                   Unkown                                                                                           [@B83]
  Heat stable enterotoxin (STa)           *V. cholerae*           Diarrhea                    Increase in electrolyte and water secretion                                                      [@B1]
  RTX                                     *V. cholerae*           Diarrhea                    Pore formation Depolymerization of the actin cytoskeleton                                        [@B16]
                                          *V. parahaemolyticus*   Diarrhea?                   Unkown                                                                                           [@B14]
                                          *V. vulnificus*         Diarrhea                    Pore formation Depolymerization of the actin cytoskeleton                                        [@B53]
  Cholix toxin                            *V. cholerae*           Extraintestinal infection   Inhibition of protein synthesis                                                                  [@B44]
  Hemagglutinin (HA)/protease (HA/P)^∗^   *V. cholerae*           Diarrhea                    Mucinase, covalent modification of other toxins, and perturbs the paracellular barrier           [@B86]; [@B58]
                                                                                                                                                                                               

∗

Not a toxin but it has been described that it may play a role during colonization of the intestine.
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